argenx SE (ARGX)
NASDAQ: ARGX · Real-Time Price · USD
774.75
-9.00 (-1.15%)
At close: Apr 28, 2026, 4:00 PM EDT
775.03
+0.28 (0.04%)
After-hours: Apr 28, 2026, 4:04 PM EDT
argenx SE Market Cap
argenx SE has a market cap or net worth of $48.47 billion as of April 28, 2026. Its market cap has increased by 46.04% in one year.
Market Cap
48.47B
Enterprise Value
44.09B
1-Year Change
46.04%
Ranking
Category
Stock Price
$774.75
Market Cap Chart
Since May 18, 2017, argenx SE's market cap has increased from $618.00M to $48.47B, an increase of 7,742.81%. That is a compound annual growth rate of 62.83%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 27, 2026 | 48.50B | -5.51% |
| Dec 31, 2025 | 51.33B | 39.57% |
| Dec 31, 2024 | 36.77B | 72.75% |
| Dec 29, 2023 | 21.29B | 2.05% |
| Dec 30, 2022 | 20.86B | 15.89% |
| Dec 31, 2021 | 18.00B | 29.92% |
| Dec 31, 2020 | 13.85B | 126.49% |
| Dec 31, 2019 | 6.12B | 96.21% |
| Dec 31, 2018 | 3.12B | 83.75% |
| Dec 29, 2017 | 1.70B | 174.53% |
View and export this data all the way back to 2017.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Vertex Pharmaceuticals | 108.36B |
| Regeneron Pharmaceuticals | 75.74B |
| Alnylam Pharmaceuticals | 41.16B |
| BeOne Medicines AG | 33.15B |
| Royalty Pharma | 29.43B |
| Insmed | 29.35B |
| Revolution Medicines | 27.69B |
| BioNTech SE | 25.81B |